MarginsXMarginsX
Home › Markets › Health Care › RMD

ResMed Inc. (RMD)

RMD trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$238.19
-0.56% on the day
Market cap
$33.5B
Large cap
Revenue · 2026
$5.7B
+9.9% on 2025
Net income · 2026
$1.5B
26.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-06-30, https://www.sec.gov/Archives/edgar/data/943819/000094381926000047/0000943819-26-000047-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-06-30.

Profile

FieldValue
TickerRMD on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000943819

Financials · 2026

LineValue
Revenue$5.7B
Net income$1.5B
Operating income$1.9B
Net margin26.9%
Operating margin33.4%
Revenue growth+9.9%
Cash$1.5B
Total assets$9.0B
P/E (computed)22.0×
P/S (computed)5.9×

Warning signs

Cash runway
Cash-flow positive
$1.0B cash at September 30, 2026
Share count, 1 year
-3.6%
2025-10-27 to 2026-10-26 · -4.4% over 3 years
Going-concern doubt
No
10-Q filed October 30, 2026
Insider net buying, 12 months
-$24.2M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-30
Cash and burn$1.0B cash; operating cash flow $442.7M a quarter.Report 2026-09-30
Shares outstanding140,657,071 (2026-10-26); 145,966,294 a year earlier; 147,091,910 three years earlier.Cover page 2026-10-26
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKPMG LLP, San Diego, California, United States; changed auditors 1 time in 24 months8-K 4.01 2026-08-17
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $24.2M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-09-30
$1.4B$418.4M$422.4M$1.0B$409.6M$5.7B10-Q 2026-10-30
Q4 2026
2026-06-30
$1.5B$383.4M$454.6M$1.5B$659.4M$5.7B10-K 2026-08-13
Q3 2026
2026-03-31
$1.4B$398.7M$554.1M$1.7B$664.1M$5.5B10-Q 2026-05-01
Q2 2026
2025-12-31
$1.4B$392.6M$339.7M$1.4B$663.8M$5.4B10-Q 2026-01-30
Q1 2026
2025-09-30
$1.3B$348.5M$457.3M$1.4B$668.6M$5.3B10-Q 2026-10-30
Q4 2025
2025-06-30
$1.3B$379.7M$538.8M$1.2B$668.3M$5.1B10-K 2026-08-13
Q3 2025
2025-03-31
$1.3B$365.0M$578.7M$932.7M$673.0M$5.0B10-Q 2026-05-01
Q2 2025
2024-12-31
$1.3B$344.6M$308.6M$521.9M$672.8M$4.9B10-Q 2026-01-30

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.

Price moves

WindowReturn
1 week+1.8%
1 month+1.9%
3 months+5.6%
Year to date-0.6%
1 year-5.0%
From 52-week high-13.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
DXCMDexCom Inc.$81.61-2.06%$30.4B
WSTWest Pharmaceutical Services Inc.$417.80+0.33%$29.1B
MDLNMedline Inc.$39.17-0.76%$51.5B
BDXBecton Dickinson and Company$216.47-0.72%$59.0B
BSXBoston Scientific Corporation$43.69-1.47%$63.3B
SOLVSolventum Corporation$88.65-0.48%$15.0B
GKOSGlaukos Corporation$244.88-0.34%$14.5B
BAXBaxter International Inc.$25.54-1.05%$13.2B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier